Duralactin Feline L-lysine is for use in cats and kittens as a supplement for clinical or latent conditions responsive to
L-lysine and MicroLactin.
Duralactin Feline L-lysine is a highly palatable paste that cats prefer 1.64 times over the leading L-lysine product and contains:
L-lysine which helps maintain respiratory and ocular health, especially in cats that are physically stressed.
MicroLactin, an immuno-nutritional aid, which helps to manage chronic inflammation.
Omega 6 and Omega 3 Fatty Acids which provide important immune system support.
Duralactin Feline L-lysine is supplied in a 32.5 ml syringe.
The dose is 2.5 ml (one notch on the syringe) twice a day for cats.
Kittens can be dosed at 1.25 ml or 1/2 notch on the syringe.
Each syringe is expected to treat one adult cat twice a day for 6.5 days.
Each dose will deliver:
•MicroLactin - 200 mg
•L-lysine - 250 mg
•Omega 6 Fatty Acids - 162 mg
•Omega 3 Fatty Acids
Duralactin® Feline L-lysine
Give directly or mix with food.
Recommended Dosage:
Adult cats:. 2.5 ml (one notch or line on syringe) twice a day
Kittens: . 1.25 ml (1/2 notch on syringe) twice a day
Using the Syringe:
Each line on the syringe corresponds with a notch that fits the wheel. The ring should be placed towards the wider part of the syringe. If the ring is at the top of the plunger, turn it to meet the wider part of the syringe, closest to the cap.
Turn the ring to the next line or notch on the syringe to deliver 2.5 ml. If 1.25 ml is desired, turn the ring between the lines or notches.
Remove the cap and press the plunger of the tube to dispense the paste into the cat's food. The paste may be mixed with food.
Some cats may prefer the paste directly from the tube. If the cap is difficult to remove, wrap a cloth around it and pull. Some paste may continue to come out of the syringe after the ring is flush with the syringe. This is normal and will stop once the cap is replaced.
When turning the ring for the last dose, it may be necessary to turn the ring firmly to get to the end of the plunger.
|
